Preservation of fertility despite subnormal gonadotropin and testosterone levels after cessation of pulsatile gonadotropin-releasing hormone therapy in a man with Kallmann’s syndrome**Supported by grants P50-HD-1262 and K0800890-01 from the National Institutes of Health, Bethesda, Maryland; research funds from the Department of Veterans Affairs; and the Clinical Research Center of the University of Washington, Seattle, Washington, supported by National Institutes of Health grant RR-37.

1994 ◽  
Vol 61 (2) ◽  
pp. 392-394 ◽  
Author(s):  
Carrie J. Bagatell ◽  
C. Alvin Paulsen ◽  
William J. Bremner
Hematology ◽  
2001 ◽  
Vol 2001 (1) ◽  
pp. 507-521 ◽  
Author(s):  
Robert F. Todd ◽  
Donald M. Miller ◽  
Roy L. Silverstein

Abstract This year the Hematology Grants Workshop, chaired by Dr. Todd, includes a comprehensive listing of available National Institutes of Health, Department of Veterans Affairs, and non-federal grants applicable to fellows and junior faculty as well as to established investigators. In Section II, Dr. Miller discusses the essential principles of successful grant writing with a special emphasis on the young investigator. He highlights the best strategies to take and the common mistakes to avoid. In Section III, Dr. Silverstein outlines the structure of the current NIH Integrated Review Group (IRG) system and the study sections of the most relevance to hematology. He traces the path that a grant takes from review to funding including the way in which grants are reviewed at NIH Study Section Meetings and provides advice in the preparation of revised applications.


Sign in / Sign up

Export Citation Format

Share Document